<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Most <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e>-associated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> are <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> which occur in a pure form </plain></SENT>
<SENT sid="1" pm="."><plain>They are rarely combined with another type of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e>, such as <z:chebi fb="32" ids="24621">endocrine</z:chebi> <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Within the <z:chebi fb="32" ids="24621">endocrine</z:chebi> spectrum, small cell <z:mp ids='MP_0002038'>carcinomas</z:mp> (SmCC) usually have a highly <z:hpo ids='HP_0000718'>aggressive behaviour</z:hpo> with a poor prognosis </plain></SENT>
<SENT sid="3" pm="."><plain>We report a case of composite SmCC and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> in the setting of a <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e>, in a 54-year-old man </plain></SENT>
<SENT sid="4" pm="."><plain>This <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> was identified on a surgical specimen after neoadjuvant treatment with radiotherapy and 5-FU-Cis-<z:chebi fb="1" ids="33364">platin</z:chebi> based chemotherapy </plain></SENT>
<SENT sid="5" pm="."><plain>The SmCC component was positive for chromogranin A, synaptophysin, neural cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule and neuron-specific enolase and negative for high molecular weight cytokeratin </plain></SENT>
<SENT sid="6" pm="."><plain>The <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> component showed a converse phenotype </plain></SENT>
<SENT sid="7" pm="."><plain>In our case, the origin of the SmCC component could be explained by the numerous chromogranin A-positive cells observed in the <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> or by the potential progenitor cells that may be located in the submucosal oesophageal gland ducts and the Barrett's <z:mpath ids='MPATH_160'>metaplasia</z:mpath> </plain></SENT>
<SENT sid="8" pm="."><plain>Our report is thus indicative of the high and totipotential risk of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Moreover, it is particular because of its favourable behaviour, with a 6-year disease-free survival, after neoadjuvant <z:e sem="disease" ids="C1559154" disease_type="Disease or Syndrome" abbrv="">chemoradiation</z:e>, surgery and postoperative chemotherapy </plain></SENT>
</text></document>